Kala Bio (KALA) Ending Cash Balance (2016 - 2026)
Kala Bio (KALA) recorded Ending Cash Balance of $229,000 in Q2 2026, down 99.3% from $31.94 million a year earlier and down 87.0% from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Ending Cash Balance (2016 - 2026) Analysis & Trends
For FY2025, Kala Bio reported Ending Cash Balance of $7.56 million, down 85.2% from FY2024.
- Annual Ending Cash Balance has a five-year compound annual growth rate of -39.0% (FY2020 to FY2025).
- Across earlier years, Ending Cash Balance came in at $51.18 million in FY2024 (+0.6%), $50.9 million in FY2023 (-28.1%), $70.75 million in FY2022 (-25.4%) and $94.88 million in FY2021 (+5.7%).
- The Q2 2026 figure is the lowest quarterly Ending Cash Balance in data going back to Q2 2016.
- On a year-over-year basis, Ending Cash Balance has declined for six consecutive quarters, with an average decline of 50.4% over the last eight quarters.
- Peak year-over-year performance for Ending Cash Balance in the last five years was growth of 119.0% in Q3 2021, against a decline of 99.3% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.76 million (Q1 2026), $7.56 million (Q4 2025) and $21.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Kala Bio | 2.38 Mn | -42.27 Mn | - | 229,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 229,000.00 |
| Mar 31, 2026 | 1.76 Mn |
| Dec 31, 2025 | 7.56 Mn |
| Sep 30, 2025 | 21.10 Mn |
| Jun 30, 2025 | 31.94 Mn |
| Mar 31, 2025 | 42.22 Mn |
| Dec 31, 2024 | 51.18 Mn |
| Sep 30, 2024 | 49.20 Mn |
| Jun 30, 2024 | 54.20 Mn |
| Mar 31, 2024 | 48.48 Mn |
| Dec 31, 2023 | 50.90 Mn |
| Sep 30, 2023 | 56.06 Mn |
| Jun 30, 2023 | 49.26 Mn |
| Mar 31, 2023 | 63.81 Mn |
| Dec 31, 2022 | 70.75 Mn |
| Sep 30, 2022 | 52.64 Mn |
| Jun 30, 2022 | 43.27 Mn |
| Mar 31, 2022 | 65.87 Mn |
| Dec 31, 2021 | 94.88 Mn |
| Sep 30, 2021 | 127.25 Mn |
API Access
Kala Bio Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();